GlassScriptPhysician profile
Bethanie L Nice
NPI 1205253580
$843.14
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $382 · 2022: $315 · 2023: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $260.74 | 2021-2023 | |
| Myovant Sciences INC. | $102.88 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.11 | 2021-2023 | |
| Organon LLC | $67.49 | 2021-2022 | |
| Evofem Biosciences, INC. | $53.74 | 2021-2022 | |
| Aspira Women'S Health INC | $49.82 | 2022-2023 | Ova1 |
| Exeltis, USA INC. | $38.00 | 2021-2023 | Slynd |
| Therapeuticsmd, INC. | $36.61 | 2021 | |
| Mayne Pharma Commercial LLC | $33.53 | 2021-2022 | |
| Avion Pharmaceuticals | $28.50 | 2022 | |
| Novo Nordisk INC | $26.71 | 2022-2023 | Wegovy |
| Phadia US INC. | $19.35 | 2023 | Immunocap |
| Acella Pharmaceuticals, LLC | $15.09 | 2023 | NP Thyroid 60 |
| Lupin INC. | $14.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethanie Nice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.